These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20569465)

  • 1. ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro.
    Drukala J; Urbanska K; Wilk A; Grabacka M; Wybieralska E; Del Valle L; Madeja Z; Reiss K
    Mol Cancer; 2010 Jun; 9():159. PubMed ID: 20569465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of PPARalpha inhibits IGF-I-mediated growth and survival responses in medulloblastoma cell lines.
    Urbanska K; Pannizzo P; Grabacka M; Croul S; Del Valle L; Khalili K; Reiss K
    Int J Cancer; 2008 Sep; 123(5):1015-24. PubMed ID: 18546270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of fenofibrate-induced metabolic catastrophe and glioblastoma cell death.
    Wilk A; Wyczechowska D; Zapata A; Dean M; Mullinax J; Marrero L; Parsons C; Peruzzi F; Culicchia F; Ochoa A; Grabacka M; Reiss K
    Mol Cell Biol; 2015 Jan; 35(1):182-98. PubMed ID: 25332241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lipid-lowering drug fenofibrate combined with si-HOTAIR can effectively inhibit the proliferation of gliomas.
    Zhu W; Zhao H; Xu F; Huang B; Dai X; Sun J; Nyalali AMK; Zhang K; Ni S
    BMC Cancer; 2021 Jun; 21(1):664. PubMed ID: 34082742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of fenofibrate-mediated anti-proliferative pro-apoptotic effects on high-grade gliomas and anti-invasive effects on glioma stem cells.
    Binello E; Mormone E; Emdad L; Kothari H; Germano IM
    J Neurooncol; 2014 Apr; 117(2):225-34. PubMed ID: 24493576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal Growth Factor (EGF) Augments the Invasive Potential of Human Glioblastoma Multiforme Cells via the Activation of Collaborative EGFR/ROS-Dependent Signaling.
    Pudełek M; Król K; Catapano J; Wróbel T; Czyż J; Ryszawy D
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor α (PPARα) contributes to control of melanogenesis in B16 F10 melanoma cells.
    Grabacka M; Wieczorek J; Michalczyk-Wetula D; Malinowski M; Wolan N; Wojcik K; Plonka PM
    Arch Dermatol Res; 2017 Apr; 309(3):141-157. PubMed ID: 28084540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenofibrate attenuates contact-stimulated cell motility and gap junctional coupling in DU-145 human prostate cancer cell populations.
    Wybieralska E; Szpak K; Górecki A; Bonarek P; Miękus K; Drukała J; Majka M; Reiss K; Madeja Z; Czyż J
    Oncol Rep; 2011 Aug; 26(2):447-53. PubMed ID: 21617875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenofibrate Attenuates Radiation-Induced Oxidative Damage to the Skin through Fatty Acid Binding Protein 4 (FABP4).
    Sun C; Song B; Sheng W; Yu D; Yang T; Geng F; Fang K; Jiao Y; Zhang J; Zhang S
    Front Biosci (Landmark Ed); 2022 Jul; 27(7):214. PubMed ID: 35866401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
    Kar D; Bandyopadhyay A
    Cell Physiol Biochem; 2018; 49(1):245-259. PubMed ID: 30138942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition.
    Panigrahy D; Kaipainen A; Huang S; Butterfield CE; Barnés CM; Fannon M; Laforme AM; Chaponis DM; Folkman J; Kieran MW
    Proc Natl Acad Sci U S A; 2008 Jan; 105(3):985-90. PubMed ID: 18199835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of fenofibrate, a peroxisome proliferator-activated receptor α agonist, on cardiac damage from sepsis in BALB/c mice.
    Lv M; Xie D; Long X
    Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(6):260-266. PubMed ID: 35818188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenofibrate enhances barrier function of endothelial continuum within the metastatic niche of prostate cancer cells.
    Piwowarczyk K; Wybieralska E; Baran J; Borowczyk J; Rybak P; Kosińska M; Włodarczyk AJ; Michalik M; Siedlar M; Madeja Z; Dobrucki J; Reiss K; Czyż J
    Expert Opin Ther Targets; 2015 Feb; 19(2):163-76. PubMed ID: 25389904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hepatokine FGF21 is crucial for peroxisome proliferator-activated receptor-α agonist-induced amelioration of metabolic disorders in obese mice.
    Goto T; Hirata M; Aoki Y; Iwase M; Takahashi H; Kim M; Li Y; Jheng HF; Nomura W; Takahashi N; Kim CS; Yu R; Seno S; Matsuda H; Aizawa-Abe M; Ebihara K; Itoh N; Kawada T
    J Biol Chem; 2017 Jun; 292(22):9175-9190. PubMed ID: 28404815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor alpha-independent effects of peroxisome proliferators on cysteinyl leukotriene production in mast cells.
    Yamashita M
    Eur J Pharmacol; 2007 Feb; 556(1-3):172-80. PubMed ID: 17113579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate lowers lipid accumulation in myotubes by modulating the PPARα/AMPK/FoxO1/ATGL pathway.
    Chen WL; Chen YL; Chiang YM; Wang SG; Lee HM
    Biochem Pharmacol; 2012 Aug; 84(4):522-31. PubMed ID: 22687626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt.
    Grabacka M; Plonka PM; Urbanska K; Reiss K
    Clin Cancer Res; 2006 May; 12(10):3028-36. PubMed ID: 16707598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms.
    Yamasaki D; Kawabe N; Nakamura H; Tachibana K; Ishimoto K; Tanaka T; Aburatani H; Sakai J; Hamakubo T; Kodama T; Doi T
    Eur J Cell Biol; 2011 Aug; 90(8):657-64. PubMed ID: 21514001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of PPARalpha-dependent and PPARalpha-independent transcript regulation following fenofibrate treatment of human endothelial cells.
    Araki H; Tamada Y; Imoto S; Dunmore B; Sanders D; Humphrey S; Nagasaki M; Doi A; Nakanishi Y; Yasuda K; Tomiyasu Y; Tashiro K; Print C; Charnock-Jones DS; Kuhara S; Miyano S
    Angiogenesis; 2009; 12(3):221-9. PubMed ID: 19357976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cells.
    Rotondi S; Modarelli A; Oliva MA; Rostomyan L; Sanita P; Ventura L; Daly AF; Esposito V; Angelucci A; Arcella A; Giangaspero F; Beckers A; Jaffrain-Rea ML
    Mol Cell Endocrinol; 2016 May; 426():61-72. PubMed ID: 26872613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.